» Articles » PMID: 37483637

The Role of Fibromodulin in Inflammatory Responses and Diseases Associated with Inflammation

Overview
Journal Front Immunol
Date 2023 Jul 24
PMID 37483637
Authors
Affiliations
Soon will be listed here.
Abstract

Inflammation is an immune response that the host organism eliminates threats from foreign objects or endogenous signals. It plays a key role in the progression, prognosis as well as therapy of diseases. Chronic inflammatory diseases have been regarded as the main cause of death worldwide at present, which greatly affect a vast number of individuals, producing economic and social burdens. Thus, developing drugs targeting inflammation has become necessary and attractive in the world. Currently, accumulating evidence suggests that small leucine-rich proteoglycans (SLRPs) exhibit essential roles in various inflammatory responses by acting as an anti-inflammatory or pro-inflammatory role in different scenarios of diseases. Of particular interest was a well-studied member, termed fibromodulin (FMOD), which has been largely explored in the role of inflammatory responses in inflammatory-related diseases. In this review, particular focus is given to the role of FMOD in inflammatory response including the relationship of FMOD with the complement system and immune cells, as well as the role of FMOD in the diseases associated with inflammation, such as skin wounding healing, osteoarthritis (OA), tendinopathy, atherosclerosis, and heart failure (HF). By conducting this review, we intend to gain insight into the role of FMOD in inflammation, which may open the way for the development of new anti-inflammation drugs in the scenarios of different inflammatory-related diseases.

Citing Articles

Identification of fibrosis-associated biomarkers in heart failure and human cancers.

Hou C, Huo J, Yan S, Sun F, Yang X J Transl Med. 2024; 22(1):1042.

PMID: 39563337 PMC: 11575019. DOI: 10.1186/s12967-024-05759-7.


Identification of immune microenvironment subtypes and clinical risk biomarkers for osteoarthritis based on a machine learning model.

Li B, Shen Y, Liu S, Yuan H, Liu M, Li H Front Mol Biosci. 2024; 11:1376793.

PMID: 39484639 PMC: 11524973. DOI: 10.3389/fmolb.2024.1376793.


Potential Targeting Mechanisms for Bone-Directed Therapies.

Celik B, Leal A, Tomatsu S Int J Mol Sci. 2024; 25(15).

PMID: 39125906 PMC: 11312506. DOI: 10.3390/ijms25158339.


Viable tendon neotissue from adult adipose-derived multipotent stromal cells.

Taguchi T, Lopez M, Takawira C Front Bioeng Biotechnol. 2024; 11:1290693.

PMID: 38260742 PMC: 10800559. DOI: 10.3389/fbioe.2023.1290693.


ASPORIN: A root of the matter in tumors and their host environment.

Lall S, Alsafwani Z, Batra S, Seshacharyulu P Biochim Biophys Acta Rev Cancer. 2023; 1879(1):189029.

PMID: 38008263 PMC: 10872503. DOI: 10.1016/j.bbcan.2023.189029.

References
1.
Halasi M, Grinstein M, Adini A, Adini I . Fibromodulin Ablation Exacerbates the Severity of Acute Colitis. J Inflamm Res. 2022; 15:4515-4526. PMC: 9374093. DOI: 10.2147/JIR.S366290. View

2.
Hedbom E, Heinegard D . Interaction of a 59-kDa connective tissue matrix protein with collagen I and collagen II. J Biol Chem. 1989; 264(12):6898-905. View

3.
Han S . Osteoarthritis year in review 2022: biology. Osteoarthritis Cartilage. 2022; 30(12):1575-1582. DOI: 10.1016/j.joca.2022.09.003. View

4.
Nguyen T, Duong C, Nguyen X, Than U . Mesenchymal Stem Cell-Derived Extracellular Vesicles for Osteoarthritis Treatment: Extracellular Matrix Protection, Chondrocyte and Osteocyte Physiology, Pain and Inflammation Management. Cells. 2021; 10(11). PMC: 8616200. DOI: 10.3390/cells10112887. View

5.
Waehre A, Halvorsen B, Yndestad A, Husberg C, Sjaastad I, Nygard S . Lack of chemokine signaling through CXCR5 causes increased mortality, ventricular dilatation and deranged matrix during cardiac pressure overload. PLoS One. 2011; 6(4):e18668. PMC: 3078912. DOI: 10.1371/journal.pone.0018668. View